Patients with serious inflammatory graves ophthalmopathy should be treated with antiinflammatory drugs or radiotherapy to prevent complications like fibrosis, while those with noninflammatory ophthalmopathy may be treated by surgery immediately. Although the majority of go patients have a mild, selflimiting, and nonprogressive ocular. Current medical therapies, which primarily consist of. A large proportion of patients with graves hyperthyroidism gh develop some degree of eye involvement. Pdf relation between therapy for hyperthyroidism and the. All patients with graves disease having regular follow up in a paediatric endocrine clinic were recruited for the study. Health, general antibodies corticosteroids glucocorticoids hypothyroidism medical research medicine, experimental methylprednisolone thyroid eye disease thyroid hormones viral antibodies. Patel is an expert in transpalpebral orbital decompression, a technique first described. Overall, a third of patients with graves disease develop some signs and symptoms of. Clinically evident ophthalmopathy occurs in 10% to 25% of unselected patients with graves disease if lid signs are excluded as a diagnostic feature, in 30% to 45% if lid signs are included, 3,11 and in approximately 70% of patients without overt eye disease if computed tomography ct or increased intraocular pressure on upgaze is used to establish the diagnosis. Given four fixed bony orbital walls, the increased intraorbital contents enlarged external ocular muscles due to lymphocytic infiltration and edema, increased retrobulbar fat cause the globe to protrude outward causing proptosis. It usually occurs in conjunction with graves hyperthyroidism. The new england journal of medicine n engl j med 364.
The ophthalmopathy or eye changes associated with thyroid disease are most often associated with the thyroid hyperfunction accompanying graves disease. It is often difficult, however, to distinguish inflammatory from noninflammatory graves disease. Case report by journal of evolution of medical and dental sciences. On imaging, it is characterized by bilateral and symmetrical enlargement of the extraocular muscle bellies. Graves disease is a frequent eye structure disorder.
We examined herein bony and softtissue ct features associated with on, including an angular assessment of orbital apex capacity, and their usefulness in the risk prediction of on. Infiltrative ophthalmopathy and primary hypothyroidism. Progressive ophthalmopathy is the most difficult component of graves disease to treat successfully. Teprotumumab for the treatment of active thyroid eye. Clinical activity score as a guide in the management of. It is unclear why the optical, mechanical, and appendicular components of the eye are. Temporal relationship between onset of graves ophthalmopathy. Graves disease the institute for advanced reconstruction. It is unclear why the optical, mechanical, and appendicular components of. Graves ophthalmopathy treatments medical clinical policy. This article is published with open access at abstract to the objective ofthisstudy istoevaluatetherole and toxicity of radiotherapy in the treatment of graves ophthalmopathy. Clinical criteria for the assessment of disease activity in.
Dickinson,3 anja eckstein,4 pat kendalltaylor,5 claudio marcocci,6 maarten p. Graves orbitopathy is an autoimmune disease of the retroocular tissues occurring in patients with graves disease. Management of thyroid eye disease graves ophthalmopathy. Graves disease is the most common cause of hyperthyroidism, with an annual incidence of 20 to 50. Graves ophthalmopathy go, the most frequent extrathyroidal manifestation of graves disease, is a disorder of autoimmune origin, the pathogenic mechanisms of which are still incompletely. To assess the quality of life in patients with graves ophthalmopathy by means of a prospective questionnaire with validation. Axial and coronal ct scans of the orbits show marked enlargement of the extraocular muscles with sparing of the tendons consistent with. Although the use of the term thyroid ophthalmopathy is pervasive, the disease process is actually. Graves disease is an autoimmune disorder characterised by an inappropriate immune. Graves ophthalmopathy go is the most important and frequent extrathyroidal expression of graves disease, although it may develop in patients with no past or present history of hyperthyroidism euthyroid or ophthalmic graves disease or, rarely, in hypothyroid hashimotos patients. Thyroidassociated orbitopathy or thyroidassociated ophthalmopathy is the most common cause of proptosis in adults and is most frequently associated with graves disease. Other clinical features include upper andor lower eyelid retraction see the second image below, restrictive myopathy causing diplopia double vision, compressive optic neuropathy, and exp.
Inferior rectus muscle restriction may mimic double elevator palsy. The temporal relationship between the onset of graves ophthalmopathy and the onset of thyroidal graves disease was evaluated in 125 consecutive patients with graves ophthalmopathy. A questionnaire containing 105 items was sent to 325 patients seen in our universitybased oculoplastic clinic. Epidemiology and natural history yuji hiromatsu 1, hiroyuki eguchi, junichi tani1, masataka kasaoka2 and yasuo teshima2 abstract graves ophthalmopathy go is an autoimmune disorder of the orbit that is clinically relevant in 2550% of patients with graves disease and 2% of patients with chronic thyroiditis. Graves disease eye disease graves disease is the only kind of hyperthyroidism that can be associated with inflammation of the eyes, swelling of the tissues around the eyes and bulging of the eyes called graves ophthalmopathy or orbitopathy. Study plan and randomisation 150 patients with newly diagnosed graves. Conversely, almost all patients with pretibial myxedema have graves ophthalmopathy, although the. A 40yearold woman in whom graves disease was recently diagnosed comes for a followup visit. Pdf background thyroidassociated ophthalmopathy, a condition commonly associated with graves disease, remains inadequately. Pdf teprotumumab for thyroidassociated ophthalmopathy. Pseudofourth nerve palsies have been described with thyroid ophthalmopathy.
The eye manifestations are diverse and include lid lag, soft tissue swelling, proptosis, corneal damage, diplopia, and optic neuropathy. The successful outcome of the present cases suggests that the timely addition of levothyroxine treatment alone or in combination with steroids is useful and effective in the management of hypothyroid. A comprehensive ophthalmic assessment including ocular motility, exophthalmometry, intraocular pressure iop, slit lamp, and fundus examinations was performed. Consensus statement of the european group on graves orbitopathy eugogo on management of graves orbitopathy luigi bartalena,1 lelio baldeschi,2 alison j. Graves ophthalmopathy and graves hyperthyroidism are closely linked, but the precise relation between these different expressions of the. Go follows a biphasic course in which an initial active phase of progression is followed by a subsequent partial regression and a static inactive phase. Images in clinical medicine from the new england journal of medicine delayed graves ophthalmopathy. Thyroid disease preceded the eye disease in 37 patients. Advances in treatment of active, moderatetosevere graves.
Tushar patel at the institute for advanced reconstruction offers a unique surgical solution for graves ophthalmopathy with excellent results. This page was last edited on 10 august 2019, at 09. The successful outcome of the present cases suggests that the timely addition of levothyroxine treatment alone or in combination with steroids is useful and effective in the management of. Mar 07, 2019 thyroidassociated orbitopathy tao, frequently termed graves ophthalmopathy, is part of an autoimmune process that can affect the orbital and periorbital tissue, the thyroid gland, and, rarely, the pretibial skin or digits thyroid acropachy. Teprotumumab for thyroidassociated ophthalmopathy nejm. We describe two such cases manifesting at different times during the course of primary hypothyroidism. Mourits,7 petros perros,8 kostas boboridis,9 antonella boschi,10. Quality of life was evaluated with the use of the graves ophthal mopathy specific qualityoflife questionnaire.
Clinical activity score as a guide in the management of patients with graves ophthalmopathy maarten ph. Relationship between disease duration and predominant orbital. To study the frequency of optic neuropathy in clinical ophthalmopathy after 12 months treatment with or without diclofenac. Trial of rituximab for graves ophthalmopathy the safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
Graves ophthalmopathy in patient with overt hypothyroidism. Listing a study does not mean it has been evaluated by the u. Trial of rituximab for graves ophthalmopathy full text. Thyroidal graves disease past or present was clinically evident in 99 patients 79%. Relation between therapy for hyperthyroidism and the course of graves ophthalmopathy article pdf available in new england journal of medicine 3382. Graves ophthalmopathy an overview sciencedirect topics.
Nejm the authorized source of trusted medical research and education for the chineselanguage medical community. Although esotropia is a more common finding with thyroid ophthalmopathy, convergence insufficiency has been described. Radiotherapy in the treatment of graves ophthalmopathy to. Ophthalmopathy in childhood graves disease british journal. Oct 25, 2011 to study the frequency of optic neuropathy in clinical ophthalmopathy after 12 months treatment with or without diclofenac. All structured data from the file and property namespaces is available under the creative commons cc0 license. Endoscan abstract on the efficacy of total or subtotal thyroid resection in the treatment of graves disease with moderatesevere endocrine ophthalmopathy. Conversely, almost all patients with pretibial myxedema have graves ophthalmopathy, although the dermopathy may precede the ophthalmopathy. Graves ophthalmopathy is a benign condition characterised by inflammation and fibrosis of the posterior orbit. In the legend for figure 2 page 996, the second sentence should have mentioned lateral rectus muscles, rather than inferi.
Graves ophthalmopathy, also known as thyroidassociated ophthalmopathy tao, occurs in 2 to 7 % of patients with graves disease with the major manifestations being proptosis, ophthalmoplegia, optic neuropathy, andor eyelid retraction. She has been taking methimazole, at a dose of 10 mg per day, and is now euthyroid, but for the past 3. Consensus statement of the european group on graves. The new england journal of medicine n engl j med 362. Thyroid eye disease ted is an autoimmune inflammatory disease of the eye and surrounding associated with tyroid disease or dysfunction. Optic neuropathy on, a serious complication of graves ophthalmopathy, is often subclinical and masked by symptoms of orbitopathy. Thyroidassociated orbitopathy radiology reference article. Graves ophthalmopathy clinical practice, n engl j med 2009. Although it has often been referred to as graves ophthalmopathy, or simply thyroid eye disease ted, it is primarily a disease of the orbit and is better termed graves orbitopathy. Koornneef orbital centre anddepartment of endocrinology, academic medical center, university of amsterdam, the netherlands received 10 september 1996.
Files are available under licenses specified on their description page. To evaluate the efficacy of radiotherapy rt with total dose of 20 gy rt 20 gy in the treatment of graves ophthalmopathy. Ophthalmopathy develops in about 30% of patients who have graves disease. Backgroundthyroidassociated ophthalmopathy, a condition commonly associated with graves disease, remains inadequately treated. Reality and perspectives luigi bartalena, aldo pinchera, and claudio marcocci dipartimento di endocrinologia e metabolismo, ortopedia e traumatologia, medicina del lavoro, university of pisa, 56124 pisa, italy abstract graves ophthalmopathy is an debilitating disease impairing the. Graves ophthalmopathy, also called graves orbitopathy, is a potentially sightthreatening ocular disease that has puzzled physicians and scientists for nearly two centuries. The pathogenesis, like that of the hyperthyroidism, is probably autoimmune in nature.
To study the ocular manifestations and their severity in children with graves disease. However, it occasionally may occur in patients with hashimotos thyroiditis and even in patients without any known thyroid disease. The most common presenting signs are orbital and periorbital edema, eyelid retraction, eyelid lag in downgaze, restrictive strabismus, compressive optic neuropathy, and exposure keratopathy. Thyroidassociated ophthalmopathy is the commonest cause of proptosis in adults. N engl j med g raves ophthalmopathy, also called graves orbitopathy, is a potentially sightthreatening ocular disease that has puzzled physicians and. In 1835 robert graves described three patients, who had bulging eyes exophthalmos associated with thyroid gland enlargement diffuse goiter, overactive thyroid gland hyperthyroidism and swelling of the skin covering the shins pretibial myxedema. The association of infiltrative ophthalmopathy with primary hypothyroidism is uncommon. Graves ophthalmopathy, also known as thyroid eye disease ted, is an autoimmune inflammatory disorder of the orbit and periorbital tissues, characterized by upper eyelid retraction, lid lag, swelling, redness, conjunctivitis, and bulging eyes exophthalmos. Graves ophthalmopathy would be desirable, but so far it is limited to secondary prevention arrest of progression of subclinical disease to clinical disease and tertiary prevention avoidance of deterioration or complications of clinical disease.
Novel approaches to the management of graves ophthalmopathy. Feb 25, 2010 graves ophthalmopathy, also called graves orbitopathy, is a potentially sightthreatening ocular disease that has puzzled physicians and scientists for nearly two centuries. Thyroid ophthalmopathy is currently is recognized as the most common cause of proptosis protrusion of the globe in adults see the first image below. The goal of therapy is local control, preferably with minimally complicating therapy. Graves ophthalmopathy is a constellation of findings, apparent in 25% to 50% of patients with graves disease, that results from edema and lymphocytic infiltration of orbital fat, connective tissue, and eye muscles.
1034 1517 1652 1314 1478 513 1324 501 1284 83 1130 280 602 1015 1101 861 41 785 1482 386 76 1434 1290 574 1061 240 461 832 23 49 1532 682 824 1308 1341 777 12 1014 259 796 960 681 303 665 433 1231 57 602 1365 949